{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:11:15Z","timestamp":1780413075015,"version":"3.54.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ncl.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T02:42:59Z","timestamp":1664332979000},"page":"755-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Maternal Use of Antiseizure Medications on Child Development"],"prefix":"10.1016","volume":"40","author":[{"given":"Kimford J.","family":"Meador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2022.03.006_bib2","series-title":"The history and stigma of epilepsy","year":"2003"},{"issue":"5","key":"10.1016\/j.ncl.2022.03.006_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archneur.1986.00520050077027","article-title":"Who was 'the father of bromide treatment of epilepsy","volume":"43","author":"Friedlander","year":"1986","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2022.03.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"issue":"7581","key":"10.1016\/j.ncl.2022.03.006_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(68)91781-9","article-title":"Anticonvulsant drugs and congenital abnormalities","volume":"2","author":"Meadow","year":"1968","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ncl.2022.03.006_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2165\/00003495-197408050-00004","article-title":"Epilepsy, anticonvulsants and congenital malformations","volume":"8","author":"Speidel","year":"1974","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(15)00398-1","article-title":"The remarkable story of valproic acid","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol"},{"issue":"42","key":"10.1016\/j.ncl.2022.03.006_bib8","first-page":"565","article-title":"Valproic acid and spina bifida: a preliminary report\u2014France","volume":"31","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.ncl.2022.03.006_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cpt.158","article-title":"Risks of congenital malformations in offspring exposed to valproic acid in utero: a systematic review and cumulative meta-analysis","volume":"98","author":"Tanoshima","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ncl.2022.03.006_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.0000000000002119","article-title":"Developmental effects of antiepileptic drugs and the need for improved regulations","volume":"86","author":"Meador","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2022.03.006_bib11","series-title":"Wyllie\u2019s treatment of epilepsy: principles & practice","first-page":"1058","article-title":"Cognitive effects of epilepsy and its treatments, Chapter 93","author":"Meador","year":"2020"},{"issue":"7","key":"10.1016\/j.ncl.2022.03.006_bib12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s11064-017-2262-4","article-title":"Neurodevelopmental effects of antiepileptic drugs","volume":"42","author":"Kellogg","year":"2017","journal-title":"Neurochem Res"},{"issue":"21","key":"10.1016\/j.ncl.2022.03.006_bib13","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hern\u00e1ndez-D\u00edaz","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2022.03.006_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2022.03.006_bib15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2022.03.006_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","article-title":"Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers","volume":"80","author":"Mawhinney","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2022.03.006_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"23","key":"10.1016\/j.ncl.2022.03.006_bib18","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2022.03.006_bib19","doi-asserted-by":"crossref","first-page":"c6581","DOI":"10.1136\/bmj.c6581","article-title":"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study","volume":"341","author":"Jentink","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib20","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1212\/WNL.0000000000007696","article-title":"Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs","volume":"93","author":"Bloti\u00e8re","year":"2019","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ncl.2022.03.006_bib21","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1111\/epi.17085","article-title":"Prenatal exposure to valproate and risk of congenital malformations-Could we have known earlier? A population-based cohort study","volume":"62","author":"Christensen","year":"2021","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.ncl.2022.03.006_bib22","doi-asserted-by":"crossref","first-page":"e1003322","DOI":"10.1371\/journal.pmed.1003322","article-title":"Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US Medicaid Analytic eXtract dataset","volume":"17","author":"Patorno","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.ncl.2022.03.006_bib23","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2022.03.006_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000154514.82948.69","article-title":"Neuropsychological effects of exposure to anticonvulsant medication in utero","volume":"64","author":"Vinten","year":"2005","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.ncl.2022.03.006_bib25","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2022.03.006_bib26","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2022.03.006_bib27","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1528-1167.2010.02668.x","article-title":"Early cognitive development in children born to women with epilepsy: a prospective report","volume":"51","author":"Bromley","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ncl.2022.03.006_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2022.03.006_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S1355617710001359","article-title":"The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy","volume":"17","author":"Nadebaum","year":"2011","journal-title":"J\u00a0Int Neuropsychol Soc"},{"key":"10.1016\/j.ncl.2022.03.006_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2022.03.006_bib31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2022.03.006_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioral functioning at age 6 years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ncl.2022.03.006_bib33","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ncl.2022.03.006_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2022.03.006_bib35","first-page":"CD010236","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2022.03.006_bib36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2022.03.006_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","article-title":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","volume":"54","author":"Deshmukh","year":"2016","journal-title":"Neurotoxicol Teratol"},{"issue":"7","key":"10.1016\/j.ncl.2022.03.006_bib38","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1037\/neu0000465","article-title":"Memory dysfunction in school-aged children exposed prenatally to antiepileptic drugs","volume":"32","author":"Barton","year":"2018","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ncl.2022.03.006_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamaneurol.2017.5035","article-title":"Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children","volume":"75","author":"Elkjaer","year":"2018","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2022.03.006_bib40","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/epi.16685","article-title":"Enduring language deficits in children of women with epilepsy and the potential role of intrauterine exposure to antiepileptic drugs","volume":"61","author":"Unnikrishnan","year":"2020","journal-title":"Epilepsia"},{"issue":"16","key":"10.1016\/j.ncl.2022.03.006_bib41","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ncl.2022.03.006_bib42","doi-asserted-by":"crossref","first-page":"e186606","DOI":"10.1001\/jamanetworkopen.2018.6606","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit\/hyperactivity disorder in offspring","volume":"2","author":"Christensen","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.ncl.2022.03.006_bib43","doi-asserted-by":"crossref","first-page":"e2025570","DOI":"10.1001\/jamanetworkopen.2020.25570","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with intellectual disability and delayed childhood milestones","volume":"3","author":"Daugaard","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ncl.2022.03.006_bib44","doi-asserted-by":"crossref","first-page":"e034829","DOI":"10.1136\/bmjopen-2019-034829","article-title":"Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study","volume":"10","author":"Bloti\u00e8re","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ncl.2022.03.006_bib45","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1038\/s41598-020-74409-x","article-title":"Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France","volume":"10","author":"Coste","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ncl.2022.03.006_bib46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/ene.14140","article-title":"Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero: the Norwegian Mother and Child Cohort Study","volume":"27","author":"Husebye","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2022.03.006_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/WNL.0b013e3182088297","article-title":"Child development following in utero exposure: levetiracetam vs sodium valproate","volume":"76","author":"Shallcross","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2022.03.006_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1212\/WNL.0000000000000030","article-title":"In utero exposure to levetiracetam vs valproate: development and language at 3 years of age","volume":"82","author":"Shallcross","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2022.03.006_bib49","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1212\/WNL.0000000000003157","article-title":"Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate","volume":"87","author":"Bromley","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ncl.2022.03.006_bib50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamaneurol.2021.1583","article-title":"Two-year-old cognitive outcomes in children of pregnant women with epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study","volume":"78","author":"Meador","year":"2021","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2022.03.006_bib51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.ncl.2022.03.006_bib52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.1994.03510340057034","article-title":"Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy","volume":"271","author":"Scolnik","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2022.03.006_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.reprotox.2014.04.005","article-title":"Developmental neurotoxicity and anticonvulsant drugs: a possible link","volume":"48","author":"Verrotti","year":"2014","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ncl.2022.03.006_bib54","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/jama.1995.03530190032031","article-title":"In utero exposure to phenobarbital and intelligence deficits in adult men","volume":"274","author":"Reinisch","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2022.03.006_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eplepsyres.2015.09.003","article-title":"Children (10-12 years age) of women with epilepsy have lower intelligence, attention and memory: observations from a prospective cohort case control study","volume":"117","author":"Gopinath","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ncl.2022.03.006_bib56","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.reprotox.2012.05.038","article-title":"Preliminary findings of the developmental effects of in utero exposure to topiramate","volume":"34","author":"Rihtman","year":"2012","journal-title":"Reprod Toxicol"},{"issue":"7","key":"10.1016\/j.ncl.2022.03.006_bib57","doi-asserted-by":"crossref","first-page":"e017248","DOI":"10.1136\/bmjopen-2017-017248","article-title":"Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis","volume":"7","author":"Veroniki","year":"2017","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ncl.2022.03.006_bib58","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1212\/WNL.0000000000006073","article-title":"Verbal abilities in children of mothers with epilepsy: association to maternal folate status","volume":"91","author":"Husebye","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamaneurol.2017.3897","article-title":"Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs in utero","volume":"75","author":"Bj\u00f8rk","year":"2018","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2022.03.006_bib60","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/ene.14140","article-title":"Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero: the Norwegian Mother and Child Cohort Study","volume":"27","author":"Husebye","year":"2020","journal-title":"Eur J Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2022.03.006_bib61","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/epi.17076","article-title":"Vitamin B status and association with antiseizure medication in pregnant women with epilepsy","volume":"62","author":"Husebye","year":"2021","journal-title":"Epilepsia"},{"issue":"suppl 1","key":"10.1016\/j.ncl.2022.03.006_bib62","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1089\/bfm.2009.0050","article-title":"A\u00a0summary of the Agency for Healthcare Research and Quality\u2019s evidence report on breastfeeding in developed countries","volume":"4","author":"Ip","year":"2009","journal-title":"Breastfeed Med"},{"issue":"22","key":"10.1016\/j.ncl.2022.03.006_bib63","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0b013e3181ffe4a9","article-title":"Effects of breastfeeding in children of women taking antiepileptic drugs","volume":"75","author":"Meador","year":"2010","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2022.03.006_bib64","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2013.4290","article-title":"Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy","volume":"70","author":"Veiby","year":"2013","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2022.03.006_bib65","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","article-title":"Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years","volume":"168","author":"Meador","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.ncl.2022.03.006_bib66","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaneurol.2019.4443","article-title":"Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy","volume":"77","author":"Birnbaum","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2022.03.006_bib67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/epi.12001","article-title":"Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero","volume":"54","author":"Campbell","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ncl.2022.03.006_bib68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1528-1167.2012.03625.x","article-title":"Teratogenesis in repeated pregnancies in antiepileptic drug-treated women","volume":"54","author":"Vajda","year":"2013","journal-title":"Epilepsia"},{"issue":"5455","key":"10.1016\/j.ncl.2022.03.006_bib69","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.287.5455.1056","article-title":"Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome","volume":"287","author":"Ikonomidou","year":"2000","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.ncl.2022.03.006_bib70","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.222550499","article-title":"Antiepileptic drugs and apoptotic neurodegeneration in the developing brain","volume":"99","author":"Bittigau","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2022.03.006_bib71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2003.tb07517.x","article-title":"Antiepileptic drugs and apoptosis in the developing brain","volume":"993","author":"Bittigau","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib72","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2004.01.025","article-title":"Therapeutic doses of topiramate are not toxic to the developing rat brain","volume":"187","author":"Glier","year":"2004","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.expneurol.2005.01.006","article-title":"Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain","volume":"193","author":"Manthey","year":"2005","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib74","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/jpet.107.123133","article-title":"Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain","volume":"322","author":"Katz","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ncl.2022.03.006_bib75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.107.126250","article-title":"Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy","volume":"323","author":"Kim","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"Suppl 5","key":"10.1016\/j.ncl.2022.03.006_bib76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2007.01285.x","article-title":"Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain","volume":"48","author":"Kim","year":"2007","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.ncl.2022.03.006_bib77","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1111\/j.1528-1167.2011.03297.x","article-title":"Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brain","volume":"52","author":"Forcelli","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ncl.2022.03.006_bib78","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/epi.13365","article-title":"Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain","volume":"57","author":"Kaushal","year":"2016","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ncl.2022.03.006_bib79","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.23600","article-title":"Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development","volume":"72","author":"Forcelli","year":"2012","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2022.03.006_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/epi.13990","article-title":"Neonatal phenobarbital exposure disrupts GABAergic synaptic maturation in rat CA1 neurons","volume":"59","author":"Al-Muhtasib","year":"2018","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.ncl.2022.03.006_bib81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1289\/ehp.94102145","article-title":"Developmental neurotoxicity induced by therapeutic and illicit drugs","volume":"102","author":"Vorhees","year":"1994","journal-title":"Environ Health Perspect"},{"issue":"3","key":"10.1016\/j.ncl.2022.03.006_bib82","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.111.188862","article-title":"Effects of neonatal antiepileptic drug exposure on cognitive, emotional, and motor function in adult rats","volume":"340","author":"Forcelli","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ncl.2022.03.006_bib83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yebeh.2014.07.010","article-title":"Brief postnatal exposure to phenobarbital impairs passive avoidance learning and sensorimotor gating in rats","volume":"37","author":"Gutherz","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ncl.2022.03.006_bib84","doi-asserted-by":"crossref","first-page":"107928","DOI":"10.1016\/j.yebeh.2021.107928","article-title":"Precision medicine in women with epilepsy: the challenge, systematic review, and future direction","volume":"118","author":"Li","year":"2021","journal-title":"Epilepsy Behav"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861922000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861922000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:22:12Z","timestamp":1760005332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861922000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0733861922000160"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2022.03.006","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Maternal Use of Antiseizure Medications on Child Development","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}